Patents by Inventor Kevin Parris

Kevin Parris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170354074
    Abstract: A new and distinct Magnolia cultivar named ‘Melissa Parris’ is disclosed, characterized by having pleasantly scented pink flowers, a strong central leader, and large tardily deciduous foliage. The new variety is a Magnolia, normally produced as a medium to large ornamental tree.
    Type: Application
    Filed: June 3, 2016
    Publication date: December 7, 2017
    Inventor: Kevin Parris
  • Publication number: 20070100560
    Abstract: This invention is directed to the crystal structures of MK2, and to the use of these structures in rational drug design methods to identify agents that may interact with active sites of MK2 proteins. Such agents may be useful as therapeutic agents.
    Type: Application
    Filed: December 6, 2006
    Publication date: May 3, 2007
    Inventors: Kevin Parris, Kathryn Underwood, Mark Stahl, Lidia Mosyak, Kristine Svenson, Tania Shane, Meggin Taylor
  • Publication number: 20070048785
    Abstract: Anti-IL-13 antibodies, crystals of anti-IL-13 antibodies, IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13 polypeptide/anti-IL-13 antibody complexes, IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, crystals of IL-13R?1 polypeptide/IL-13 polypeptide/anti-IL-13 antibody complexes, and related methods and software systems are disclosed.
    Type: Application
    Filed: June 9, 2005
    Publication date: March 1, 2007
    Inventors: Laura Lin, Kevin Parris, Amy Sze Tam, Xiang-Yang Tan, Tania Shane, John Dumas, James Wilhelm, Mark Stahl, Lidia Mosyak, Zhixiang Hu
  • Publication number: 20060063228
    Abstract: This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
    Type: Application
    Filed: June 9, 2005
    Publication date: March 23, 2006
    Inventors: Marion Kasaian, Lioudmila Tchistiakova, Geertruida Veldman, Kimberly Marquette, Xiang-Yang Tan, Debra Donaldson, Laura Lin, Tania Shane, Amy Tam, Eric Feyfant, Nancy Wood, Lori Fitz, Angela Widom, Kevin Parris, Samuel Goldman, Jose Saldanha
  • Patent number: PP29707
    Abstract: A new and distinct Magnolia cultivar named ‘Melissa Parris’ is disclosed, characterized by having pleasantly scented pink flowers, a dominant central leader, and large tardily deciduous foliage. The new variety is a Magnolia, normally produced as a medium to large ornamental tree.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: September 25, 2018
    Assignee: Idelwylde Ornamentals
    Inventors: Blaine Childress, Kevin Parris